[Chronic myelomonocytic leukemia with repeated respiratory failure associated with leukocytosis following splenic arterial embolization and splenectomy].
A 32-year-old female was admitted due to splenomegaly and leukocytosis in September, 1993. The leukocyte count was 26,900/microliter with 29% monocytes (7,800/microliter). A diagnosis of the chronic phase of chronic myelomonocytic leukemia was made. On November 19, 1993, splenic arterial embolization was performed. After the embolization, the leukocyte count rapidly increased, and acute respiratory failure developed. The respiratory condition was improved by methylprednisolone (m-PRED) pulse therapy. Subsequently, the effectiveness of chemotherapy gradually decreased, and there was an increase in the leukocyte count. Respiratory failure developed again but was successfully treated with m-PRED pulse therapy in addition to aclarubicin. On July 4, 1995, splenectomy was performed. The leukocyte count rapidly increased, and acute respiratory failure again developed. She did not respond to m-PRED pulse therapy, but the respiratory condition was markedly improved by leukoplasmapheresis. The respiratory failure in this patient may be associated with capillary leak syndrome due to neutrophilia. In addition, stasis of increased monocytes in the pulmonary capillaries and their infiltration into the pulmonary parenchyma and alveoli was thought to have occurred.
Takimoto
Y
Y
Department of Internal Medicine, Hiroshima Asa City Hospital.
Imanaka
F
F
D000328:Adult; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D007937:Leukapheresis; D015477:Leukemia, Myelomonocytic, Chronic / Q000150:complications*; D007964:Leukocytosis / Q000209:etiology*; D008775:Methylprednisolone / Q000008:administration & dosage; D012131:Respiratory Insufficiency / Q000209:etiology* / Q000628:therapy; D013156:Splenectomy; D013157:Splenic Artery
D008775:Methylprednisolone